It is conceivable that this dynamic adjustment of DC subsets induced by Bev treatment we distinctively visualize in vivo reflects several modifications of physical and chemical communication between innate immune cells and tumor cells, favoring the escape of the tumor to VEGF blockade [39]. The gene discussed is VEGFA; the disease is neoplasm.